Kronos Bio Terminates Material Definitive Agreement
| Field | Detail |
|---|---|
| Company | Kronos Bio, Inc. |
| Form Type | 8-K |
| Filed Date | Apr 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: agreement-termination, material-event
TL;DR
Kronos Bio just terminated a big deal. Heads up.
AI Summary
Kronos Bio, Inc. announced on April 8, 2025, the termination of a material definitive agreement. The company, incorporated in Delaware, is headquartered in San Mateo, California, with its principal executive offices located at 1300 S. El Camino Real, Suite 400.
Why It Matters
The termination of a material definitive agreement can significantly impact a company's strategic direction and financial obligations.
Risk Assessment
Risk Level: medium — Termination of a material definitive agreement can indicate underlying issues or strategic shifts that may pose risks to the company's future performance.
Key Numbers
- 001-39592 — SEC File Number (Identifies the company's filing with the SEC.)
- 1231 — Fiscal Year End (Indicates the end of the company's fiscal year.)
Key Players & Entities
- Kronos Bio, Inc. (company) — Registrant
- April 8, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Mateo, California (location) — City and State of principal executive offices
- 1300 S. El Camino Real, Suite 400 (address) — Principal executive offices address
FAQ
What specific material definitive agreement was terminated?
The filing does not specify the exact name or details of the material definitive agreement that was terminated.
What is the reason for the termination of the agreement?
The filing states that the event is the 'Termination of a Material Definitive Agreement' but does not provide the specific reasons for the termination.
When was the agreement originally entered into?
The filing does not disclose the date when the material definitive agreement was originally entered into.
Are there any financial implications or penalties associated with this termination?
The filing does not detail any financial implications or penalties resulting from the termination of the agreement.
Does this termination affect any ongoing operations or partnerships of Kronos Bio, Inc.?
The filing does not provide information on whether this termination impacts ongoing operations or partnerships.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 10, 2025 regarding Kronos Bio, Inc..